Dr. Mamoon M. Elbedawi, MD

Dr. Elbedawi practices at Crowne Point Endoscopy and Surgery Center in Flint, Michigan.

Dr. Elbedawi's NPI, 1770662553, was assigned on November 3, 2006. Dr. Elbedawi graduated from University of Gezira Faculty of Medicine in 1991. Dr. Elbedawi holds Michigan license 4301104217.

Dr. Elbedawi's primary practice is Crowne Point Endoscopy and Surgery Center, at 6240 Rashelle Drive, Suite 101, Flint, MI 48507. The practice phone is (810) 600-4000.

Dr. Elbedawi's primary practice is Crowne Point Endoscopy and Surgery Center in Flint, Michigan. Dr. Elbedawi is also affiliated with Hurley Medical Center. The medical group on file is Mid Michigan Gastroenterology Associates. Dmand AI also links Dr. Elbedawi to 4 more hospitals, 2 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elbedawi practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Elbedawi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Elbedawi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Elbedawi's licenses on file in 5 states: Michigan, Florida, Virginia, District of Columbia and Maryland.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Elbedawi treats.

CMS data shows 4,171 Medicare services from Dr. Elbedawi across 24 procedure codes in 2024, for 1,059 Medicare patients. Medicare paid $350,774 for them.

CMS counts 1,059 Medicare patients who saw Dr. Elbedawi in 2024. The largest group is 65 to 74, with 370 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elbedawi's median patient age at 63, with 57% women.

In 2024, Dr. Elbedawi wrote 1,174 Medicare Part D claims for 771 patients. 71% of them were for generic drugs. CMS names the drug for 1,046 of them, across 16 drugs with 11 or more claims each, at $217,040 in total drug cost. In 2023, CMS named 1,095 claims across 23 drugs.

Dr. Elbedawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 735 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Elbedawi, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Elbedawi, published from 2007 to 2021. 2020 was the busiest year, with 4. Dr. Elbedawi's most frequent co-authors are Grigoriy E. Gurvits, MD, Murtaza Hussain, MD and Adil Abubaker Abdalla, MD.

Dmand AI links Dr. Elbedawi to 2 clinical trials. University of Florida sponsors the most, 2.

CMS Open Payments shows 542 general payments to Dr. Elbedawi from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Allergan Inc. paid the most, $12,054.

Dr. Elbedawi graduated from University of Gezira Faculty of Medicine in 1991.

Dr. Elbedawi is in network with 19 carriers, including Aetna, Elevance and Health Alliance Plan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.